Homocysteine and arterial disease: Experimental mechanisms
- 31 May 2002
- journal article
- review article
- Published by Elsevier in Vascular Pharmacology
- Vol. 38 (5) , 293-300
- https://doi.org/10.1016/s1537-1891(02)00254-9
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- Association of mild hyperhomocysteinemia with cardiac graft vascular diseaseAtherosclerosis, 1998
- Cystathionine-β-synthase deficiency: Detection of heterozygotes by the ratios of homocystein to cysteine and folateMetabolism, 1998
- Homocysteine mediated endothelial cell toxicity and its ameliorationAtherosclerosis, 1996
- Lipid peroxidation and susceptibility of low‐density lipoprotein to in vitro oxidation in hyperhomocysteinaemiaEuropean Journal of Clinical Investigation, 1995
- Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal statusEuropean Journal of Clinical Investigation, 1992
- Higher total plasma homocysteine in vitamin B12 deficiency than in heterozygosity for homocystinuria due to cystathionine β-synthase deficiencyMetabolism, 1988
- Identification of a thrombin sequence with growth factor activity on macrophages.Proceedings of the National Academy of Sciences, 1986
- Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial DiseaseNew England Journal of Medicine, 1985
- Moderate homocysteinemia--a possible risk factor for arteriosclerotic cerebrovascular disease.Stroke, 1984
- Chemotactic response of monocytes to thrombin.The Journal of cell biology, 1983